Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,354 | -76,698 | -68,362 | -157,868 | -31,888 |
| Depreciation Amortization | 749 | 1,015 | 765 | 515 | 265 |
| Accounts receivable | -6,278 | 5,323 | -6,314 | -855 | 2,033 |
| Accounts payable and accrued liabilities | 3,813 | 4,474 | 4,044 | 4,728 | 3,735 |
| Other Working Capital | -2,789 | 6,018 | 1,455 | 1,084 | 5,405 |
| Other Operating Activity | 1,919 | -10,542 | 4,533 | 104,817 | -469 |
| Operating Cash Flow | $-4,940 | $-70,410 | $-63,879 | $-47,579 | $-20,919 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -341 | -306 | -236 | -66 |
| Investing Cash Flow | $-3 | $-341 | $-306 | $-236 | $-66 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,640 | 11,500 | 10,000 | 10,000 | 10,000 |
| Debt Repayment | N/A | -5,892 | -5,892 | -5,892 | N/A |
| Common Stock Issued | 61 | 57,551 | 57,551 | 53,262 | 5,480 |
| Common Stock Repurchased | N/A | -18 | -18 | -18 | N/A |
| Other Financing Activity | 0 | -1,202 | -1,202 | -859 | -351 |
| Financing Cash Flow | $1,701 | $61,939 | $60,439 | $56,493 | $15,129 |
| Beginning Cash Position | 4,776 | 13,588 | 13,588 | 13,588 | 13,588 |
| End Cash Position | 1,534 | 4,776 | 9,842 | 22,266 | 7,732 |
| Net Cash Flow | $-3,242 | $-8,812 | $-3,746 | $8,678 | $-5,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,940 | -70,410 | -63,879 | -47,579 | -20,919 |
| Capital Expenditure | -3 | -341 | -306 | -236 | -66 |
| Free Cash Flow | -4,943 | -70,751 | -64,185 | -47,815 | -20,985 |